Skip to content
Screener

AngioDynamics ANGO Free cash flow

Free cash flow at other companies

Abbott logo
AbbottABT
$1.99B+28.9%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$633M-54.7%
TFX
TeleflexTFX
$77.86M+220%
Stryker logo
StrykerSYK
$1.06B+14.1%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$24.67M+26.5%
ICU Medical logo
ICU MedicalICUI
$61.64M—

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M—
CapEx$413.0K-46.8%

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S2×+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%—

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Calculated from AngioDynamics’s reported figures.

$17.5Mnet cash from operating−$413.0Kcapital expenditures=$17.04M

The source filing: AngioDynamics’s 10-K, filed July 14, 2026. Open the filing →

Filed
Jul 14, 2026, 3:42 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-048138

FAQ

What is AngioDynamics's free cash flow?
AngioDynamics (ANGO) reported free cash flow of $17.04M in Q1 2026.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about AngioDynamics's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude